EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Intervention in Herpes Simplex Virus-1 Replication in Vitro with Allenic Macrolide Archangiumide

You Li, Jia-Qi Hu iD, Wen-Hai Feng, Changsheng Wu, Li Gao

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26041537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von You Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Biotech Breeding, Frontiers Science Center for Molecular Design Breeding, Ministry of Agriculture Key Laboratory of So…. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Virus Replication, Macrolides, Antiviral Agents. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Earmarked Fund for Modern Agro-Industry Technology Research System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Archangiumide is a unique macrolide natural product that features an endocyclic allene functionality, rendering it a prototype of a new class of secondary metabolites of microbial origin. However, its biological and/or pharmaceutical roles remain obscure. In this study, we have unveiled an antiviral potency of archangiumide that was effective against herpes simplex virus (HSV-1) replication. We found that archangiumide did not affect host cell viability, nor pathogen infectivity, but suppressed HSV-1 early replication, in terms of early replication genes, such as ICP0, ICP4, etc. Further scrutinizing the underlined master regulator, we found that HSV-1 VP16 protein expression was inhibited by archangiumide, as well as VP16 nuclear translocation. As VP16 is a coactivator of transcription, archangiumide harnessed the master regulator of HSV-1 early replication. Together, here we provide evidence that allene macrolide archangiumide possesses robust antiviral functions that may be valuable for a novel viral infection intervention, as macrolides are generally safe drugs for prolonged treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanVirus ReplicationMacrolidesAntiviral AgentsChlorocebus aethiopsAnimalsVero CellsHumansHerpes Simplex

Stichwörter der Autor:innen

HSV-1antiviralarchangiumide

Substanzen

MacrolidesAntiviral Agents

Autor:innen und Institutionen

  • State Key Laboratory of Animal Biotech Breeding, Frontiers Science Center for Molecular Design Breeding, Ministry of Agriculture Key Laboratory of Soil Microbiology, Department of Microbiology and Immunology, College of…
  • State Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao 266237, China.
  • National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
  • Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, College of Veterinary Medcine, China Agricultural University, Beijing 100193, China.

ORCID-Profile: Jia-Qi Hu

Förderung

  • National Key Research and Development Program of China
  • Earmarked Fund for Modern Agro-Industry Technology Research System

Zitieren

APA

Li, Y., Hu, J. Q., Feng, W. H., Wu, C., & Gao, L. (2025). Early Intervention in Herpes Simplex Virus-1 Replication in Vitro with Allenic Macrolide Archangiumide. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041537

Vancouver

Li Y, Hu JQ, Feng WH, Wu C, Gao L. Early Intervention in Herpes Simplex Virus-1 Replication in Vitro with Allenic Macrolide Archangiumide. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041537

BibTeX
@article{Li2025,
  author = {Li, You and Hu, Jia-Qi and Feng, Wen-Hai and Wu, Changsheng and Gao, Li},
  title = {Early Intervention in Herpes Simplex Virus-1 Replication in Vitro with Allenic Macrolide Archangiumide},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26041537}
}
Kostenlos starten →